Altos Labs Stock

altoslabs.comHealthcareFounded: 2021Funding to Date: $1.16B

Altos Labs manufactures beauty products using biological reprogramming to reverse the aging process and offer anti-aging treatments.

Register for Details

For more details on financing and valuation for Altos Labs, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Altos Labs.

Register Today

Altos Labs investors also invested in these private companies

Jeff Bezos
Yuri Milner

Team

Management Team

Hal Barron
Incoming Chief Executive Officer
Hans Bishop
Founder & President
Rick Klausner
Founder & Chief Scientist
Ann Lee-Karlon
Chief Operating Officer
Yuri Milner
Founder
Laurie Hill
General Counsel

Board Members

Jennifer Doudna
University of California
Robert Nelsen
ARCH Venture Partners
Frances Arnold
California Institute of Technology
Maria Leptin
EMBL
Karl Johansson
David Baltimore
Emeritus & Caltech
Rajiv Shah
Rockefeller Foundation

Other companies like Altos Labs in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.34B

News

Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming. Altos' mission is to restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life. The company launches with a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission.